相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Innovation Forager: Stimulating Academic Innovation
Thomas Ungar et al.
ACADEMIC MEDICINE (2014)
Genome Editing-Enabled HIS Assays Expand Drug Target Pathways for Charcot-Marie-Tooth Disease
James Inglese et al.
ACS CHEMICAL BIOLOGY (2014)
Phytochemicals Perturb Membranes and Promiscuously Alter Protein Function
Helgi I. Ingolfsson et al.
ACS CHEMICAL BIOLOGY (2014)
Pharmacophore Reassignment for Induction of the Immunosurveillance Cytokine TRAIL
Nicholas T. Jacob et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
A biochemical screen for GroEL/GroES inhibitors
Steven M. Johnson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Development of novel pyrazolone derivatives as inhibitors of aldose reductase: An eco-friendly one-pot synthesis, experimental screening and in silico analysis
Aparna Kadam et al.
BIOORGANIC CHEMISTRY (2014)
From HTS to Phase I: The Institute for Therapeutics Discovery and Development at the University of Minnesota
Peter I. Dosa et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2014)
A Unique Industrial - Academic Collaboration Towards the Next Generation of Schizophrenia Therapeutics
Gregor J. Macdonald et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
To screen or not to screen: an impassioned plea for smarter chemical libraries to improve drug lead finding
Gerry Lushington et al.
FUTURE MEDICINAL CHEMISTRY (2014)
The essential roles of chemistry in high-throughput screening triage
Jayme L. Dahlin et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Rapid Identification of Keap1-Nrf2 Small-Molecule Inhibitors through Structure-Based Virtual Screening and Hit-Based Substructure Search
Chunlin Zhuang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of Innovative Therapeutics: Today's Realities and Tomorrow's Vision. 2. Pharma's Challenges and Their Commitment to Innovation
Magid Abou-Gharbia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Undecaprenyl Diphosphate Synthase Inhibitors: Antibacterial Drug Leads
William Sinko et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo
Fardokht Abulwerdi et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Chemical con artists foil drug discovery
Jonathan Baell et al.
NATURE (2014)
The cellular thermal shift assay for evaluating drug target interactions in cells
Rozbeh Jafari et al.
NATURE PROTOCOLS (2014)
Can you trust your animal study data?
Ian S. Peers et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Rescuing US biomedical research from its systemic flaws
Bruce Alberts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Systems biology-embedded target validation: improving efficacy in drug discovery
Drieke Vandamme et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2014)
Putative Impact of RNA Editing on Drug Discovery
Niels Decher et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2013)
A Proposal Regarding Reporting of In Vitro Testing Results
Malcolm A. Smith et al.
CLINICAL CANCER RESEARCH (2013)
Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines
D. C. Swinney
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Innovation in academic chemical screening: filling the gaps in chemical biology
Samuel A. Hasson et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2013)
NIPTE: a multi-university partnership supporting academic drug development
Vadim J. Gurvich et al.
DRUG DISCOVERY TODAY (2013)
Broad Coverage of Commercially Available Lead-like Screening Space with Fewer than 350,000 Compounds
Jonathan B. Baell
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Development of Highly Potent and Selective Diaminothiazole Inhibitors of Cyclin-Dependent Kinases
Ernst Schonbrunn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Dual Myxovirus Screen Identifies a Small-Molecule Agonist of the Host Antiviral Response
Dan Yan et al.
JOURNAL OF VIROLOGY (2013)
Structure-guided design of a selective BCL-XL inhibitor
Guillaume Lessene et al.
NATURE CHEMICAL BIOLOGY (2013)
Target validation using chemical probes
Mark E. Bunnage et al.
NATURE CHEMICAL BIOLOGY (2013)
The epigenetics pipeline
Vivian A. DeWoskin et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Validating therapeutic targets through human genetics
Robert M. Plenge et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
The Basics of Translation
Huda Y. Zoghbi
SCIENCE (2013)
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Daniel Martinez Molina et al.
SCIENCE (2013)
How academic labs can approach the drug discovery process as a way to synergize with big pharma
Arianna Loregian et al.
TRENDS IN MICROBIOLOGY (2013)
Metal Impurities Cause False Positives in High-Throughput Screening Campaigns
Johannes C. Hermann et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Drug Discovery in an Academic Setting: Playing to the Strengths
Donna M. Huryn
ACS MEDICINAL CHEMISTRY LETTERS (2013)
A Lack of Premature Termination Codon Read-Through Efficacy of PTC124 (Ataluren) in a Diverse Array of Reporter Assays
Stuart P. McElroy et al.
PLOS BIOLOGY (2013)
Challenges for Academic Drug Discovery
William L. Jorgensen
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Structural Biology and Drug Discovery of Difficult Targets: The Limits of Ligandability
Sachin Surade et al.
CHEMISTRY & BIOLOGY (2012)
Can we discover pharmacological promiscuity early in the drug discovery process?
Jens-Uwe Peters et al.
DRUG DISCOVERY TODAY (2012)
Drug discovery in pharmaceutical industry: productivity challenges and trends
Ish Khanna
DRUG DISCOVERY TODAY (2012)
Relevance of systems pharmacology in drug discovery
Lourdes Cucurull-Sanchez et al.
DRUG DISCOVERY TODAY (2012)
What makes a good drug target?
Isabella Gashaw et al.
DRUG DISCOVERY TODAY (2012)
Development of a Rule-Based Method for the Assessment of Protein Druggability
Emanuele Perola et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Discovery and Synthesis of Hydronaphthoquinones as Novel Proteasome Inhibitors
Yiyu Ge et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Rules for Identifying Potentially Reactive or Promiscuous Compounds
Robert F. Bruns et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Identification of a Novel Family of BRAFV600E Inhibitors
Jie Qjn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
A Preclinical Evaluation of Minnelide as a Therapeutic Agent Against Pancreatic Cancer
Rohit Chugh et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Therapeutics Development for Cystic Fibrosis: A Successful Model for a Multisystem Genetic Disease
Melissa A. Ashlock et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Target Validation: Linking Target and Chemical Properties to Desired Product Profile
Paul G. Wyatt et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Druggability assessment of protein-protein interfaces
Jutta Wanner et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Discovery and Characterizatlion of Small Molecule Inhibitors of the BET Family Bromodomains
Chun-wa Chung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
KNIME Workflow to Assess PAINS Filters in SMARTS Format. Comparison of RDKit and Indigo Cheminformatics Libraries
Simon Saubern et al.
MOLECULAR INFORMATICS (2011)
US academic drug discovery
Stephen Frye et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Trends in the exploitation of novel drug targets
Mathias Rask-Andersen et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Believe it or not: how much can we rely on published data on potential drug targets?
Florian Prinz et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Structural conservation of druggable hot spots in protein-protein interfaces
Dima Kozakov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Organic synthesis toward small-molecule probes and drugs
Stuart L. Schreiber
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
How to Revive Breakthrough Innovation in the Pharmaceutical Industry
Bernard H. Munos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Probing the Probes: Fitness Factors For Small Molecule Tools
Paul Workman et al.
CHEMISTRY & BIOLOGY (2010)
Apparent activity in high-throughput screening: origins of compound-dependent assay interference
Natasha Thorne et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
The translatability of animal models for clinical development: biomarkers and disease models
Alexandra Wendler et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Towards a more robust approach to selecting and prosecuting promising targets and compounds
Graeme Robertson
FUTURE MEDICINAL CHEMISTRY (2010)
Observations on screening-based research and some concerning trends in the literature
Jonathan B. Baell
FUTURE MEDICINAL CHEMISTRY (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness
Julie A. Frearson et al.
NATURE (2010)
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Gideon Bollag et al.
NATURE (2010)
Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124
Douglas S. Auld et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Driving Drug Discovery: The Fundamental Role of Academic Labs
B. Michael Silber
SCIENCE TRANSLATIONAL MEDICINE (2010)
Investigating the factors that diminish the barriers to university-industry collaboration
Johan Bruneel et al.
RESEARCH POLICY (2010)
Quantifying Biological Activity in Chemical Terms: A Pharmacology Primer To Describe Drug Effect
Terry Kenakin
ACS CHEMICAL BIOLOGY (2009)
A survey of across-target bioactivity results of small molecules in PubChem
Lianyi Han et al.
BIOINFORMATICS (2009)
In vivo target validation using gene invalidation, RNA interference and protein functional knockout models: it is the time to combine
Olivier Vidalin et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Predicting druggable binding sites at the protein-protein interface
Jonathan C. Fuller et al.
DRUG DISCOVERY TODAY (2009)
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Frank Lovering et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4
Costas A. Lyssiotis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Best Practices in Compound Management for Preserving Compound Integrity and Accurately Providing Samples for Assays
Sandra L. Matson et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
A structural biology view of target drugability
Ursula Egner et al.
EXPERT OPINION ON DRUG DISCOVERY (2008)
High-throughput screening assays for the identification of chemical probes
James Inglese et al.
NATURE CHEMICAL BIOLOGY (2007)
PTC124 targets genetic disorders caused by nonsense mutations
Ellen M. Welch et al.
NATURE (2007)
Drug discovery in jeopardy
Pedro Cuatrecasas
JOURNAL OF CLINICAL INVESTIGATION (2006)
Screening the receptorome: an efficient approach for drug discovery and target validation
Ryan T. Strachan et al.
DRUG DISCOVERY TODAY (2006)
Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries
James Inglese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A detergent-based assay for the detection of promiscuous inhibitors
Brian Y. Feng et al.
NATURE PROTOCOLS (2006)
Obtaining and screening compound collections: a user's guide and a call to chemists
PJ Hergenrother
CURRENT OPINION IN CHEMICAL BIOLOGY (2006)
Towards a proteome-scale map of the human protein-protein interaction network
JF Rual et al.
NATURE (2005)
Target-based drug discovery: is something wrong?
F Sams-Dodd
DRUG DISCOVERY TODAY (2005)
ALARM NMR: A rapid and robust experimental method to detect reactive false positives in biochemical screens
JR Huth et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Risk reduction in drug discovery and development
M Mackay et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
Designing screens: How to make your hits a hit
WP Walters et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Virtual drug discovery and development for neglected diseases through public-private partnerships
S Nwaka et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
分享论文
